There is theoretical evidence to support the use of angiotensin converting enzyme inhibitors and, if not tolerated, angiotensin receptor blockers in the treatment of asymptomatic or symptomatic HF ACHD patients. The gene discussed is ACE; the disease is hydrops fetalis.